Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00002668

Locations


United States, Illinois
	CCOP - Carle Cancer Center
	Urbana, Illinois, United States, 61801

United States, Iowa
	CCOP - Cedar Rapids Oncology Project
	Cedar Rapids, Iowa, United States, 52403-1206
	CCOP - Iowa Oncology Research Association
	Des Moines, Iowa, United States, 50309-1016
	Iowa Lutheran Hospital
	Des Moines, Iowa, United States, 50316-2301
	John Stoddard Cancer Center at Iowa Methodist Medical Center
	Des Moines, Iowa, United States, 50309
	Mercy Cancer Center at Mercy Medical Center-Des Moines
	Des Moines, Iowa, United States, 50314

United States, Louisiana
	CCOP - Ochsner
	New Orleans, Louisiana, United States, 70121

United States, Minnesota
	CCOP - Metro-Minnesota
	Saint Louis Park, Minnesota, United States, 55416

United States, Nebraska
	Midlands Cancer Center at Midlands Community Hospital
	Papillion, Nebraska, United States, 68128-4157

United States, New Jersey
	CCOP - Northern New Jersey
	Hackensack, New Jersey, United States, 07601

United States, New Mexico
	MBCCOP - University of New Mexico HSC
	Albuquerque, New Mexico, United States, 87131

United States, Pennsylvania
	CCOP - MainLine Health
	Wynnewood, Pennsylvania, United States, 19096
	Penn State Cancer Institute at Milton S. Hershey Medical Center
	Hershey, Pennsylvania, United States, 17033-0850

United States, South Dakota
	CCOP - Sioux Community Cancer Consortium
	Sioux Falls, South Dakota, United States, 57104

United States, Wisconsin
	CCOP - St. Vincent Hospital Cancer Center, Green Bay
	Green Bay, Wisconsin, United States, 54307-3453

Australia, New South Wales
	Westmead Hospital
	Westmead, New South Wales, Australia, 2145

Peru
	Instituto de Enfermedades Neoplasicas
	Lima, Peru, 34

Puerto Rico
	San Juan City Hospital
	San Juan, Puerto Rico, 00936-7344

Sponsors and Collaborators

Eastern Cooperative Oncology Group

National Cancer Institute (NCI)

Investigators


Study Chair:	Charles Cleeland, PhD	M.D. Anderson Cancer Center